Furazolidone Tablets

The main ingredient of this product is furazolidone. Chemical name: 3-(5-nitrofurfural amino)-oxazolidinone [2]. Molecular weight: C8H7O5N3

This product is a sugar-coated tablet or a film-coated tablet.

Oral administration. The usual dose for adults is 0.1g once, 3-4 times a day; for children, 5-10mg/kg per day, divided into 4 doses according to body weight. The course of treatment for intestinal infection is 5-7 days, and the course of treatment for giardiasis is 7-10 days.

The main symptoms include nausea, vomiting, diarrhea, headache, dizziness, drug fever, rash, anal itching, asthma, orthostatic hypotension, hypoglycemia, pulmonary infiltration, etc., and occasionally hemolytic anemia, jaundice and multiple neuritis may occur.

It is contraindicated for those who are allergic to this product.

Precautions for children: Not for use in newborns. Precautions for pregnancy and lactation: Not for use in pregnant and lactating women. Precautions for the elderly: Not yet clear.

1. The combination with tricyclic antidepressants may cause acute toxic psychosis and should be avoided. 2. This product can enhance the effect of levodopa. 3. Sympathomimetic amines, tyramine-rich foods, appetite suppressants, monoamine oxidase inhibitors, etc. can enhance the effect of this product.

seal.

100s

24 months

North China Pharmaceutical Hebei Huanuo Co., Ltd.

• Founded in:

  2004-12-15

• Address:

  No. 53, Zhangju Road, Luancheng District, Shijiazhuang City, Hebei Province

• Tax NO.:

  91130100769813764U

• Registered Funds:

  100 million yuan

• Email:

  Log in to view